Pure Scientific Technologies will focus its development efforts along two parallel paths using its patent-pending technology
devices for the rapidly growing holistic cannabidiol (CBD) market
devices for the treatment of lung diseases using FDA approved pharmaceuticals
The initial thrust of PST’s product development will be hand-held and desktop versions of inhalers for the CBD market, as Pure Scientific Technologies believes the fundamental improvement in aerosol delivery with Heliox offers strong near term financial opportunity with minimal regulatory oversite.
Early design development knowledge will then be leveraged into new products for delivery of pharmaceuticals directly into the lungs for treatment of lung disease, and ultimately diseases affecting other body sites.
To Design, Develop, Produce and Market new and innovative products based on its patent-pending technologies utilizing Heliox, Helium and other gases to enhance and accelerate absorption of pharmaceuticals and CBD through the lungs into the bloodstream.